Earlier this year, Cincinnati Children’s used a new type of imaging technique to help diagnose children affected by some types of pulmonary conditions such as cystic fibrosis, asthma, or bronchiolitis obliterans. Normally these diseases are identified with CT; the downside is that there is a small safety risk in the form of radiation exposure.
“Jason Woods, PhD, director of research in the division of Pulmonary Medicine at Cincinnati Children’s, has been investigating a way to alleviate these concerns. For more than 20 years, he has researched Xe gas to pioneer a safer, faster, and more precise method for pinpointing lung disease. This research culminated in the launch of the Xenon-129 MRI Clinical Trials Consortium in 2015, which began exploring the potential of hyperpolarized Xe gas imaged via radiation-free magnetic resonance imaging (MRI) as a standardized tool at other sites.”
To learn more about this new imaging technique using xenon gas and MRI, visit our Cincinnati Children’s News Release site! (Click here)